<?xml version="1.0" encoding="UTF-8"?><!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com --><!-- Created: Tue Sep 22 15:59:07 UTC 2026 --><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:common="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002155983</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>08/20/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001679628</issuerCik>
        <issuerName>Jupiter Neurosciences, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>48208B203</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <common:street1>11621 Kew Garden Avenue, Suite 210</common:street1>
          <common:city>Palm Beach</common:city>
          <common:stateOrCountry>FL</common:stateOrCountry>
          <common:zipCode>33410</common:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>PharmAla Biotech Holdings Inc.</reportingPersonName>
      <citizenshipOrOrganization>A6</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>132867</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>132867</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>132867</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>17.3</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>Based on 770,081 outstanding Issuer shares</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Jupiter Neurosciences, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>11621 Kew Gardens Avenue, Suite 210, Palm Beach Gardens FL 33410</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>PharmAla Biotech Holdings Inc.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>1 Adelaide Street E., Suite 801
Toronto, Ontario M5C 2VP Canada</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Ontario, Canada</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>132,867</amountBeneficiallyOwned>
        <classPercent>17.3</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>132,867</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>132,867</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>PharmAla Biotech Holdings Inc.</reportingPersonName>
<!-- [WMV7][zg6YRCFRPTk5cr+vAEtfkylqo9aHdWGEb6rKzYd9Ns72FrsqgzS6ehC43N8pASN8aLTvpU8FSTKl7O4V2xWNVKXLqCIwZiHJ7mkbrjbP3fZ7k8dR6M5gQgBqssAa4t7tM6/fbDHNRKGNhLve0ASEKWARZoAMFLTqNsOp/3qh7QuNAWITgY9M2yCnCxoKsKrq/7PUgGYWrGUvwBYV7a93+umbgiCdZRsvI6OfelLkWWP8h5soAMXjw2jmhuHYYNkzFHJ6FtDBB+UgZMfJFAiDWtjfYeerk22+R7jIM25ExA5+dkhyAeMhNtyQiB6xcOlpNGOGIk8Imfcsvpjf/Q==] CSR-->
      <signatureDetails>
        <signature>/s/ William Avery</signature>
        <title>Chief Financial Officer</title>
        <date>09/22/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
